Nuvation Bio, Inc. (NUVB)
4.59
+0.02
(+0.44%)
USD |
NYSE |
Mar 06, 16:00
4.45
-0.14
(-3.05%)
Pre-Market: 20:00
Nuvation Bio Total Assets (Quarterly) : 594.82M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 838.03M |
| Aldeyra Therapeutics, Inc. | 72.06M |
| Indivior Pharmaceuticals, Inc. | 1.204B |
| Terns Pharmaceuticals, Inc. | 301.65M |
| Biohaven Ltd. | 451.45M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 289.11M |
| Shareholders Equity (Quarterly) | 305.72M |
| Debt to Equity Ratio | 0.6959 |
| Current Ratio | 6.950 |
| Net Debt Paydown Yield | -1.31% |